Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
Jovanovic JV, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G, Erben P, Popp H, Walz C, Hochhaus A, Roche-Lestienne C, Preudhomme C, Solomon E, Apperley J, Rondoni M, Ottaviani E, Martinelli G, Brito-Babapulle F, Saglio G, Hehlmann R, Cross NC, Reiter A, Grimwade D. Jovanovic JV, et al. Among authors: popp h. Blood. 2007 Jun 1;109(11):4635-40. doi: 10.1182/blood-2006-10-050054. Epub 2007 Feb 13. Blood. 2007. PMID: 17299092 Free article.
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C, Popp H, Haferlach T, Erben P, Mix J, Müller MC, Beneke H, Müller L, Del Valle F, Aulitzky WE, Wittkowsky G, Schmitz N, Schulte C, Müller-Hermelink K, Hodges E, Whittaker SJ, Diecker F, Döhner H, Schuld P, Hehlmann R, Hochhaus A, Cross NC, Reiter A. Metzgeroth G, et al. Among authors: popp h. Leukemia. 2007 Jun;21(6):1183-8. doi: 10.1038/sj.leu.2404662. Epub 2007 Mar 22. Leukemia. 2007. PMID: 17377585 Clinical Trial.
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study.
Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, Haferlach C, Fabarius A, Schnittger S, Grimwade D, Cross NC, Hehlmann R, Hochhaus A, Reiter A. Metzgeroth G, et al. Among authors: popp h. Br J Haematol. 2008 Dec;143(5):707-15. doi: 10.1111/j.1365-2141.2008.07294.x. Epub 2008 Oct 17. Br J Haematol. 2008. PMID: 18950453 Free article. Clinical Trial.
Photomediated Hexafluoroisopropoxylation of Unactivated Aryl Halides.
Boyden B, Tobin S, Haen N, Metz A, Wojnowiak C, Taylor T, Cutty A, Litza A, Stiles I, Soehner N, Oberbroeckling A, O'Leary N, Popp H, MacKenzie I. Boyden B, et al. Among authors: popp h. Chemistry. 2024 Dec 5;30(68):e202402811. doi: 10.1002/chem.202402811. Epub 2024 Oct 29. Chemistry. 2024. PMID: 39194305
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases.
Rotterdam J, Thiaucourt M, Weiss C, Schwaab J, Reiter A, Kreil S, Steiner L, Fenchel S, Popp HD, Hofmann WK, Bonatz K, Gerhards C, Neumaier M, Klein SA, Rao S, Jawhar M, Saussele S. Rotterdam J, et al. Among authors: popp hd. Ann Hematol. 2022 Aug;101(8):1825-1834. doi: 10.1007/s00277-022-04866-z. Epub 2022 May 21. Ann Hematol. 2022. PMID: 35597847 Free PMC article.
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis.
Naumann N, Lübke J, Baumann S, Schwaab J, Hoffmann O, Kreil S, Dangelo V, Reiter L, Bugert P, Kristensen T, Sotlar K, Haselmann V, Schneider S, Metzgeroth G, Weiss C, Popp HD, Fabarius A, Hofmann WK, Cross NCP, Reiter A, Jawhar M. Naumann N, et al. Among authors: popp hd. Int J Mol Sci. 2021 Mar 4;22(5):2562. doi: 10.3390/ijms22052562. Int J Mol Sci. 2021. PMID: 33806359 Free PMC article.
71 results